Skip to main content

Table 7 Associations between patient-related parameters and psychotropic drug treatment If value 1 is not included in the 95% confidence interval, a significant association is indicated (p < 0.05); these results are printed in bold. 95% Confidence interval (lower boundary, upper boundary)

From: A bitter pill to swallow - Polypharmacy and psychotropic treatment in people with advanced dementia

Parameters

 

Antipsychotics (N05A) OR (CI 95%)

Antidepressants (N06A) OR (CI 95%)

Sedatives (=antipsychotic + anxiolytic + hypnotic drugs) OR (CI 95%)

Pain medication (=N02A+N02B) OR (CI 95%)

Sex

male

0.97 (0.51-1.85)

0.86 (0.45-1.67)

0.94 (0.51-1.75)

0.49 (0.19-1.22)

female

Reference

   

Place of living

LTC

1.94 (0.96-3.93)

0.94 (0.47-1.90)

1.63 (0.83-3.18)

3.32 (1.18-9.37)

HC

Reference

   

Dementia onset

LOD

1.01 (0.37-2.82)

1.07 (0.37-3.08)

0.74 (0.28-1.98)

0.81 (0.21-3.14)

YOD

Reference

   

Dementia etiology

FTLD

0.35 (0.15-0.83)

1.15 (0.52-2.54)

0.38 (0.17-0.86)

0.98 (0.33-2.22)

Others

1.01 (0.35-2.90)

2.91 (1.04-8.16)

1.23 (0.45-3.39)

0.34 (0.06-1.89)

AD

Reference

   

CDR (sum of boxes)

 

1.28 (0.87-1.88)

0.72 (0.51-1.03)

1.08 (0.76-1.53)

1.14 (0.60-2.18)

QUALID

 

1.03 (0.97-1.10)

1.03 (0.97-1.10)

1.04 (0.97-1.10)

1.02 (0.93-1.11)

PAINAD

 

1.04 (0.85-1.27)

0.96 (0.79-1.17)

0.99 (0.82-1.20)

1.25 (0.98-1.60)

Barthel-Index

 

1.01 (0.99-1.02)

1.00 (0.98-1.02)

1.00 (0.98-1.02)

0.99 (0.96-1.01)

NPI total

 

1.04 (1.01-1.07)

0.99 (0.96-1.01)

1.04 (1.01-1.07)

0.98 (0.95-1,02)

EOLD SM total

 

1.02 (0.97-1.07)

0.94 (0.89-1.00)

1.04 (0.99-1.09)

0.99 (0.92-1.06)

Age*

 

0.78 (0.49-1.25)

0.68 (0.41-1.11)

0.84 (0.53-1.32)

1.21 (0.64-2.29)

  1. AD Alzheimer’s disease, CI Confidence Interval, CDR Clinical Dementia Rating scale, EOLD-SM End of life in dementia: Symptom-Management, FTLD frontotemporal lobar degeneration, LOD late onset dementia, NPI Neuropsychiatric Inventory, OR odds ratio, PAINAD Pain Assessment in Dementia, QUALID Quality of life in late stage dementia, YOD young onset dementia; *age was entered into the model with a multiplication factor of 0.1